Sisaf
Guildford, GB · Founded 2008 · 17 employees on LinkedIn · 2 known investors
Find your way into Sisaf
115 people in our graph share verified history with the Sisaf team — schools, employers, funds. One of them is your warm intro.
Cordelia Roydsunlockedknows Dr. Suzanne Saffie-Siebert · together at Oxford Brookes University (overlapped)
×11knows the team · via Oxford Brookes University
SiSaf is an RNA delivery and therapeutics company that uses its proprietary bioabsorbable silicon-based Bio-Courier technology to deliver nucleic acids, avoiding the ultra-cold supply chain of conventional lipid nanoparticles. It is developing a pipeline of RNA therapeutics targeting pancreatic cancer, metastatic cancer, and the rare skeletal disease osteopetrosis ADO2.
Founders & leadership
Sisaf was founded in 2008 by Dr. Suzanne Saffie-Siebert.
DS
Dr. Suzanne Saffie-SiebertinFounder · Chairwoman & CEODr. Suzanne Saffie-Siebert is founder and CEO of SiSaf, an RNA delivery company developing therapeutics using bioabsorbable silicon-based technology. She has over 25 years of experience in pharmaceuticals and holds patents in drug delivery systems.
Investors · 2
Frequently asked questions
- What does Sisaf do?
- SiSaf is an RNA delivery and therapeutics company that uses its proprietary bioabsorbable silicon-based Bio-Courier technology to deliver nucleic acids, avoiding the ultra-cold supply chain of conventional lipid nanoparticles. It is developing a pipeline of RNA therapeutics targeting pancreatic cancer, metastatic cancer, and the rare skeletal disease osteopetrosis ADO2.
- Who founded Sisaf?
- Sisaf was founded by Dr. Suzanne Saffie-Siebert in 2008.
- Who are Sisaf's investors?
- Sisaf's investors include Clarendon Fund Managers Ltd., Vickers Venture Partners.
- Where is Sisaf headquartered?
- Sisaf is headquartered in Guildford, GB.